Health Influencers: Bioactive Compounds against Obesity
DOI:
https://doi.org/10.22201/ceide.16076079e.2024.25.4.2Keywords:
bioactive compounds, health, obesity, gut microbiota, wetern dietAbstract
Bioactive compounds are chemical substances found within plants and their derivatives. These compounds have been of special interest in science, since they have been shown to have beneficial effects on health and diseases such as obesity and its comorbidities. The prevalence of obesity in our country is increasing, because of lifestyle changes and an unhealthy diet, such as the so-called western diet. Benefits related to the consumption of bioactive compounds are attributed on one hand to the fact that they have antioxidant protective effects and that they fight inflammation. In the other hand, they also interact with and balance the millions of microorganisms that live in our gut, known as microbiota. This is why we could consider bioactive compounds as the influencers of health. To get all its benefits, it is necessary to increase the consumption of plant-based foods of all colors in our diet, to help prevent and treat obesity and other diseases such as diabetes and cancer.
References
Agunloye, O. M., Oboh, G., Ademiluyi, A. O., Ademosun, A. O., Akindahunsi, A. A., Oyagbemi, A. A., Omobowale, T. O., Ajibade, T. O., y Adedapo, A. A. (2019). Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: Mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats. Biomedicine & Pharmacotherapy, 109, 450-458. https://doi.org/10.1016/j.biopha.2018.10.044
Barber, T. M., Kabisch, S., Pfeiffer, A. F., y Weickert, M. O. (2023). The effects of the mediterranean diet on health and gut microbiota. Nutrients, 15(9), 2150. https://doi.org/10.3390/nu15092150
Fontané, L., Benaiges, D., Goday, A., Llauradó, G., y Pedro-Botet, J. (2018). Influencia de la microbiota y de los probióticos en la obesidad. Clínica e Investigación en Arteriosclerosis, 30(6), 271-279. https://doi.org/10.1016/j.arteri.2018.03.004
López Gamboa, Y., Gamboa Pellicier, Y., y Rodríguez Cantillo, Y. (2021). Microbiota intestinal y obesidad. Ciencia Latina Revista Científica Multidisciplinar, 5(6), 11033-11043. https://doi.org/10.37811/cl_rcm.v5i6.1152
Irfan, H. (2023). Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the select Trial. Current Problems in Cardiology, 49, 102060. https://doi.org/10.1016/j.cpcardiol.2023.102060
Lin, X., y Li, H. (2021). Obesity: Epidemiology, Pathophysiology, and Therapeutics. Frontiers in endocrinology, 12, 706978. https://doi.org/10.3389/fendo.2021.706978
Lynch, S. V., y Pedersen, O. (2016). The human intestinal microbiome in health and disease. New England Journal of Medicine, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
Samanta, S., Chakraborty, S., & Bagchi, D. (2024). Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components. Journal of the American Nutrition Association, 43(1), 20–32. https://doi.org/10.1080/27697061.2023.2203235
Shamah-Levy, T., Romero-Martínez, M., Barrientos-Gutiérrez, T., Cuevas-Nasu, L., Bautista-Arredondo, S., Colchero, M. A., Gaona-Pineda, E. B., Lazcano-Ponce, E., Martínez-Barnetche, J., Alpuche-Arana, C., y Rivera-Dommarco, J. (2022). Encuesta Nacional de Salud y Nutrición 2021 sobre Covid-19. Resultados nacionales. Instituto Nacional de Salud Pública. https://tinyurl.com/389xwyda
Stevens, Y., Rymenant, E. V., Grootaert, C., Van Camp, J., Possemiers, S., Masclee, A., y Jonkers, D. (2019). The intestinal fate of citrus flavanones and their effects on gastrointestinal health. Nutrients, 11(7), 1464. https://doi.org/10.3390/nu11071464
Urquiaga, I., Echeverría, G., Dussaillant, C., y Rigotti, A. (2017). Origen, componentes y posibles mecanismos de acción de la dieta mediterránea. Revista médica de Chile, 145(1), 85-95. https://doi.org/m38b
Vekic, J., Zeljkovic, A., Stefanovic, A., Jelic-Ivanovic, Z., y Spasojevic-Kalimanovska, V. (2019). Obesity and dyslipidemia. Metabolism, 92, 71-81. https://doi.org/10.1016/j.metabol.2018.11.005
Yoshida H. (2021). Preventive and Ameliorating Effects of Food Factors on Obesity-related Diseases by Regulating Inflammation. Yakugaku zasshi, 141(10), 1161–1171. https://doi.org/10.1248/yakushi.21-00121
Zhao, Y., Chen, B., Shen, J., Wan, L., Zhu, Y., Yi, T., y Xiao, Z. (2017). The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxidative medicine and cellular longevity, 1459497. https://doi.org/10.1155/2017/1459497
Published
Issue
Section
License
Copyright (c) 2024 Revista Digital Universitaria
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Revista Digital Universitaria es editada por la Universidad Nacional Autónoma de México se distribuye bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional. Basada en una obra en http://revista.unam.mx/.
